Kinetic Concepts pays $1.7bn in cash for LifeCell
Kinetic Concepts (KCI; wound healing devices and therapeutic support beds and surfaces) has agreed to pay $1.7bn cash (or $51 per share, a 19% premium) to acquire all of publicly owned LifeCell's (regenerative tissue repair) 34mm outstanding shares.
- Medical Devices
- Implantable Devices
- Full Acquisition
- Includes Contract
- Payment Includes Cash for Equity
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.